Hot Pursuit     09-Mar-22
Biocon Ltd gains for third straight session
Biocon Ltd is quoting at Rs 338, up 1.06% on the day as on 12:54 IST on the NSE. The stock is down 16.04% in last one year as compared to a 7.32% jump in NIFTY and a 6.35% jump in the Nifty Pharma index.

Biocon Ltd is up for a third straight session today. The stock is quoting at Rs 338, up 1.06% on the day as on 12:54 IST on the NSE. The benchmark NIFTY is up around 1.7% on the day, quoting at 16285. The Sensex is at 54444.92, up 1.91%. Biocon Ltd has slipped around 16.27% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has slipped around 3.8% in last one month and is currently quoting at 12844.85, up 1.95% on the day. The volume in the stock stood at 16.1 lakh shares today, compared to the daily average of 38.38 lakh shares in last one month.

The benchmark March futures contract for the stock is quoting at Rs 339, up 0.94% on the day. Biocon Ltd is down 16.04% in last one year as compared to a 7.32% jump in NIFTY and a 6.35% jump in the Nifty Pharma index.

The PE of the stock is 348.65 based on TTM earnings ending December 21.

Previous News
  Barometers pares all gains ; realty shares decline
 ( Market Commentary - Mid-Session 24-May-24   10:36 )
  Board of Biocon recommends final dividend
 ( Corporate News - 16-May-24   17:54 )
  Biocon's new monoclonal antibodies facility in India get manufacturing approval from EMA
 ( Hot Pursuit - 24-Jun-24   09:34 )
  Biocon reports consolidated net profit of Rs 660.00 crore in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   07:41 )
  Biocon subsidiary launches biosimilar for Humira in US
 ( Hot Pursuit - 04-Jul-23   08:56 )
  Biocon
 ( Results - Analysis 28-Jul-22   10:30 )
  Biocon CFO resigns
 ( Corporate News - 08-Feb-24   19:43 )
  Biocon signs exclusive licensing and supply agreement with Handok
 ( Corporate News - 24-May-24   09:06 )
  Biocon arm completes integration of Viatris biosimilars biz
 ( Hot Pursuit - 07-Sep-23   09:45 )
  Biocon
 ( Results - Analysis 16-Nov-22   18:05 )
  Biocon standalone net profit declines 43.72% in the March 2022 quarter
 ( Results - Announcements 29-Apr-22   07:59 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top